Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History EW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics EW

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Edwards Lifesciences Corp

EW
Current price
76.18 USD 0 USD (0.00%)
Last closed 76.81 USD
ISIN US28176E1082
Sector Healthcare
Industry Medical Devices
Exchange NYSE
Capitalization 46 224 080 896 USD
Yield for 12 month -11.22 %
1Y
3Y
5Y
10Y
15Y
EW
21.11.2021 - 28.11.2021

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Address: One Edwards Way, Irvine, CA, United States, 92614

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

81.01 USD

P/E Ratio

32.56

Dividend Yield

Financials EW

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures EW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+5 439 500 000 USD

Last Year

+6 004 800 000 USD

Current Quarter

+1 412 700 000 USD

Last Quarter

+1 385 800 000 USD

Current Year

+4 322 000 000 USD

Last Year

+4 625 000 000 USD

Current Quarter

+1 112 500 000 USD

Last Quarter

+1 093 600 000 USD
EBITDA 1 686 000 000 USD
Operating Margin TTM 29.02 %
Price to Earnings 32.56
Return On Assets TTM 8.42 %
PEG Ratio 4.30
Return On Equity TTM 16.51 %
Wall Street Target Price 81.01 USD
Revenue TTM 5 522 299 904 USD
Book Value 17.28 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 6.20 %
Dividend Yield
Gross Profit TTM 4 390 099 968 USD
Earnings per share 2.42 USD
Diluted Eps TTM 2.42 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY 4.20 %
Profit Margin 75.71 %

Stock Valuation EW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 32.56
Forward PE 31.65
Enterprise Value Revenue 7.62
Price Sales TTM 8.37
Enterprise Value EBITDA 23.73
Price Book MRQ 4.47

Technical Indicators EW

For 52 Weeks

58.93 USD 91.49 USD
50 Day MA 76.21 USD
Shares Short Prior Month 7 383 664
200 Day MA 71.95 USD
Short Ratio 1.39
Shares Short 6 072 158
Short Percent 1.18 %